Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO

Clinical trial NCT02800642 · COMPLETED

Trial details

NCT number: NCT02800642
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Central Retinal Vein Occlusion

Start date: 2016-06-10
Primary completion: 2019-07-31
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.